Also, TMZ combined with PARP1 inhibitor olaparib significantly inhibited tumor growth in mice in the HG7R NC group, which was consistent with the enhanced TMZ sensitivity induced by ATRX knockout in the HG7R KO group. Here, PARP1 is linked to neoplasm.